AstraZeneca PLC
AZN
#61
Rank
$257.866 B
Marketcap
United Kingdom
Country
$166.27
Share price
4.74%
Change (1 day)
5.68%
Change (1 year)
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company offers Imjudo, Datroway, Iressa, Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Crestor, Andexxa, Onglyza, Symlin, XIGDUO XR, Atacand, Atacand HCT, Atacand Plus, Farxiga/Forxiga, Plendil, Modip, Splendil, Munobal, Flodil,…
Key Metrics
Trailing P/E
24.87
Forward P/E
14.35
EPS (TTM)
$6.68
Forward EPS
$11.58
Price / Book
5.12
EV / EBITDA
14.3x
Beta
0.20
Dividend Yield
1.97%
Return on Equity
21.96%
Return on Assets
8.02%
Debt / Equity
64.22
Current Ratio
0.89
Gross Margin
81.69%
Operating Margin
23.46%
Net Profit Margin
17.02%
Free Cash Flow
$4.905B
Charts
Price history and financial performance over time.
Price & Market Cap
Aug 19 – Sep 17
+0.72%
Source: Yahoo Finance daily closes. Market cap uses the closest quarterly shares-outstanding filing for each date.
Revenue & Net Income
Annual · USD
RevenueNet Income
Latest Revenue$58.739B
Latest Net Income$10.225B
Reporting periods4
Source: Yahoo Finance annual income statements. Year is the fiscal-year end. Most recent period may be trailing-twelve-month (TTM) until the next 10-K is filed.
Compare AstraZeneca PLC with competitors
Side-by-side market cap, revenue, and financial comparison.
Latest News
Latest News
AZN
No recent news available. Set FINNHUB_API_KEY to enable news.
